声带肉毒毒素注射治疗难治性矛盾性声带运动障碍
本回顾性研究纳入13例经喉部控制训练、药物治疗和生物反馈治疗仍存在呼吸困难的矛盾性声带运动障碍(PVFMD)患者,评估声带肉毒毒素注射的疗效。平均每侧声带剂量2.55单位,平均注射3.85次;13例中11例(84.6%)呼吸困难改善,其中2例(18.2%)症状完全缓解;呼吸困难严重指数(DSI)均值由注射前30.43改善至注射后17.43(P=0.017)。所有患者出现暂时性声嘶,无其他不良反应。作者认为该治疗安全有效,对规范药物及呼吸再训练后仍难治者应考虑使用。
要点
- 13例难治性PVFMD患者接受声带肉毒毒素注射,平均每侧2.55单位,平均注射3.85次。
- 11/13(84.6%)呼吸困难改善,其中2/11(18.2%)完全缓解;DSI均值由30.43降至17.43(P=0.017)。
- 所有患者出现暂时性声嘶,无其他不良反应;证据等级4。
核心结论
- 声带肉毒毒素注射是PVFMD安全有效的治疗选择,对规范药物治疗及呼吸再训练后仍难治的呼吸困难患者应考虑使用。
研究设计与样本
- 回顾性综述,纳入诊断为PVFMD且因呼吸困难症状经喉部控制治疗、药物治疗和生物反馈治疗仍持续而接受声带肉毒毒素注射的患者13例(女9例/男4例)。
主要发现
- 平均剂量为每侧声带2.55单位(范围1.75-5.5单位),平均注射次数3.85次(范围1-12次)。
- 13例中11例(84.6%)呼吸困难症状改善,11例中2例(18.2%)症状完全缓解。
- DSI均值注射前30.43,注射后改善至17.43(P=0.017)。
- 所有患者出现暂时性声嘶,无其他不良反应。
临床怎么用
- 作者认为声带肉毒毒素注射是PVFMD安全有效的治疗选择,对规范药物治疗及呼吸再训练方案后仍难治的呼吸困难患者应考虑使用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Demonstrate efficacy of vocal fold botulinum toxin injection for treatment of refractory paradoxical vocal fold motion disorder (PVFMD). METHODS: A retrospective review was completed of patients diagnosed with PVFMD who underwent vocal fold botulinum toxin injection for dyspnea symptoms that persisted despite laryngeal control therapy, medical management, and biofeedback therapy. Outcomes measured included overall improvement and resolution of dyspnea symptoms, number of botulinum toxin injections and dose range, change in dyspnea severity index (DSI) scores, and adverse effects of injection therapy. RESULTS: Thirteen patients (9 female/4 male) underwent vocal fold botulinum toxin injection for refractory PVFMD. The average dose was 2.55 units per vocal fold (range 1.75-5.5 units). The average number of injections was 3.85 (range 1-12 injections). Eleven of 13 (84.6%) patients experienced improvement in dyspnea symptoms, with two of 11 (18.2%) having complete resolution of symptoms. There was a statistically significant improvement in DSI scores because the mean preinjection DSI was 30.43 and improved to 17.43 postinjection (P = 0.017). Temporary breathy voice quality was experienced by all patients with no other adverse side effects. CONCLUSION: Vocal fold botulinum toxin injection is a safe and effective treatment option for PVFMD and should be considered in patients with refractory dyspnea symptoms following appropriate medical therapy and respiratory retraining protocols. LEVEL OF EVIDENCE: 4 Laryngoscope, 129:808-811, 2019.
引用
- deSilva B, Crenshaw D, Matrka L, et al. Vocal fold botulinum toxin injection for refractory paradoxical vocal fold motion disorder. Laryngoscope. 2018. PMID: 30548857. doi:10.1002/lary.27471
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。